Everlywell developed an at-home COVID-19 testing collection kit that is limitedly available based on state restrictions. It is FDA authorized to perform at home and will digitally provide results within 72 hours of the lab receiving the swab sample. Furthermore, the platform also offers free telehealth consultation services with a physician to guide them through following steps respectively. It is notable that the test cost can be reimbursed by healthcare insurance with no profit to Everlywell.
If one is eligible for the test, the kit will be received at home, followed by an online screening and unique kit ID registration, the nasal swab is them performed and it must be dropped off on the same day. Results will be returned within a 72 hour time period confirming the presence of absence of the virus.
Self-Performed Virus Test Kits
Everlywell's COVID-19 Test Home Collection Kit is FDA Authorized
Trend Themes
1. At-home COVID-19 Test Kits - There is a growing trend of developing at-home test kits for COVID-19, providing convenience and accessibility for individuals to test themselves for the virus.
2. Telehealth Consultation Services - Telehealth consultation services are on the rise, allowing individuals to connect with healthcare professionals remotely for guidance and support during the testing process.
3. Reimbursement by Healthcare Insurance - The trend of healthcare insurance reimbursing the cost of at-home COVID-19 test kits, such as Everlywell's, creates opportunities for wider adoption and affordability for individuals.
Industry Implications
1. Healthcare - The healthcare industry can explore opportunities to develop and market at-home test kits for various diseases to meet the growing demand for convenient and accessible testing.
2. Telemedicine - The telemedicine industry can capitalize on the trend of telehealth consultation services by developing innovative platforms and technologies that enhance the remote healthcare experience for patients.
3. Insurance - Insurance companies can leverage the trend of reimbursing the cost of at-home COVID-19 test kits and expand coverage to include other preventive measures, encouraging individuals to take proactive steps towards their health.